Recent efficacy and long-term survival of Astragalus polysaccharide combined with gemcitabine and S-1 in pancreatic cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

1073

Figures (1-1)

Tables (1-4)

Sum=1181

Publishing Process of This Article

Item

Count

Browse

Download

Sum=64

Nov 24, 2024 (publication date) through Nov 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Nov 24, 2024; 15(11): 1404-1411
Published online Nov 24, 2024. doi: 10.5306/wjco.v15.i11.1404

Figure 1 Survival curves. APS: Astragalus polysaccharide; GS: Gemcitabine plus tegafur gimeracil oteracil potassium capsule (S-1).

Citation: Li GY, Jiang J. Recent efficacy and long-term survival of Astragalus polysaccharide combined with gemcitabine and S-1 in pancreatic cancer. World J Clin Oncol 2024; 15(11): 1404-1411
URL: https://www.wjgnet.com/2218-4333/full/v15/i11/1404.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i11.1404